Published September 25, 2025 | Version v1

PLD data for manuscript "Interdisciplinary Study on Drug-Induced-Phospholipidosis of Repurposing Libraries through Machine Learning and Experimental Evaluation in Different Cell Lines"

  • 1. ROR icon Fraunhofer Institute for Translational Medicine and Pharmacology
  • 2. ROR icon Karolinska Institutet

Description

Phospholipidosis (PLD), a cellular adverse effect that is, among others, caused by numerous cationic amphiphilic drugs. Interest is raised within pharma discovery to predict this phenomenon, as it can impact the outcome of phenotypic cellular screens and significantly delay drug development processes. The development of accurate and validated machine learning models for predicting drug-induced PLD across different cell lines and research centers could provide a valuable early application tool for the pharmaceutical industry, potentially accelerating drug discovery and reducing the risk of late-stage failures. We provide here one of the largest datasets of repurposed drugs (5K+) tested for PLD induction on different cell lines. The data ser was used for assembly, curation, testing and ML model development. In addition, we provide the ChEMBL v34 based target-list for the 58 hit compounds, that induced PLD in two tested cell lines.

Files

Supp_Annotated_targets_to_PLD_hits.csv

Files (886.1 kB)

Name Size Download all
md5:1b7432928c00a81e2aeebb098406d1cc
92.9 kB Preview Download
md5:e8eac48013f9430602d3b138bc026b7b
793.1 kB Download

Additional details

Funding

European Commission
REMEDI4ALL - BUILDING A SUSTAINABLE EUROPEAN INNOVATION PLATFORM TO ENHANCE THE REPURPOSING OF MEDICINES FOR ALL 101057442